Yüklüyor......
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Heart failure affects approximately 5.7 million people in the United States alone. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, and aldosterone antagonists have improved mortality in patients with heart failure and reduced ejection fraction, but mortality r...
Kaydedildi:
| Yayımlandı: | Circulation |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800749/ https://ncbi.nlm.nih.gov/pubmed/26976916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.115.018622 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|